Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-11

Clinical Trial Update: 1.2% Atorvastatin and 1.2% Simvastatin in Treatment of Chronic Periodontitis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluated 1.2% atorvastatin and 1.2% simvastatin for the treatment of chronic periodontitis. The study was conducted by the Governme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)
  • atorvastatin (atorvastatin)

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Chronic Periodontitis | Phase 2, Phase 3 | Status: COMPLETED